Compared to paired normal tissues, FDX1 expression levels were upregulated in glioblastoma (GBM) and female genital tumors, and downregulated in solid tumors like lung adenocarcinoma (LUAD) and hepatocellular carcinoma (HCC) [95]. This evidence concerns the gene FDX1 and hepatocellular carcinoma.